UPC

Universe Pharmaceuticals INC Stock Price

NasdaqCM:UPC Community·US$2.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

UPC Share Price Performance

US$5.00
-184.30 (-97.36%)
US$5.00
-184.30 (-97.36%)
Price US$5.00

UPC Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards

Universe Pharmaceuticals INC Key Details

US$19.3m

Revenue

US$13.4m

Cost of Revenue

US$5.9m

Gross Profit

US$15.5m

Other Expenses

-US$9.6m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
-17.08
30.41%
-49.87%
14.0%
View Full Analysis

About UPC

Founded
1998
Employees
225
CEO
Gang Lai
WebsiteView website
www.universe-pharmacy.com

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sells of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Recent UPC News & Updates

Universe Pharmaceuticals INC's (NASDAQ:UPC) Prospects Need A Boost To Lift Shares

Sep 10
Universe Pharmaceuticals INC's (NASDAQ:UPC) Prospects Need A Boost To Lift Shares

Recent updates

No updates